News

SALUS’s presence at Swiss HLG

We are excited to reflect on our time at the Swiss HLG Conference in Montreux.

The conference provided an excellent opportunity to connect with pharmaceutical leaders, exchange insights, and explore how innovation continues to shape the future of patient care.

We look forward to building new collaborations, strengthening existing partnerships, and further advancing access to innovative therapies for patients around the world.

Latest News

A new chapter in our story.Salus has signed a share purchase agreement (SPA) for the acquisition of a 100 % stake in Farmedica, a specialist ...

We are proud to partner with Oncopeptides to expand access to Pepaxti® across Central and Eastern Europe. A targeted therapy for patients with multiple myeloma ...